Product Design, Manufacturing & Innovation Resources

Dernières publications et brevets en immunologie et vaccinologie

Immunologie Vaccinologie

Astuce : suite à la sélection ci-dessous, vous pouvez rechercher et filtrer nos 2 bases de données complètes :

> outil de recherche de publications gratuit < par auteur, sujet, mots-clés, date ou revue.

> outil gratuit de recherche de brevets < pour les brevets en anglais de l'Office européen des brevets.

Immunologie
Les progrès en immunologie et en vaccinologie permettent de concevoir et d'optimiser des vaccins et des systèmes d'administration efficaces.

Immunology and vaccinology cover the mechanisms governing immune system function and the development of prophylactic and therapeutic vaccines. This domain integrates cellular and molecular immunology, antigen recognition, immune memory, and host-pathogen interactions to design and optimize vaccine formulations, adjuvants, and delivery systems. Research addresses immune modulation, immunopathology, and strategies to enhance vaccine efficacy against infectious diseases, cancers, and autoimmune disorders. Our continuously updated compilation presents the latest peer-reviewed studies and patented technologies advancing immunological understanding and vaccine innovation:

Voici notre dernière sélection de publications et de brevets mondiaux en anglais sur l'immunologie et la vaccinologie, parmi de nombreuses revues scientifiques en ligne, classées et axées sur l'antigène, l'anticorps, la cellule T, la cellule B, l'immunogène, l'épitope, l'adjuvant, l'immunisation, l'efficacité du vaccin, la réponse immunitaire, la cellule mémoire, la cytokine, l'immunoglobuline, l'anticorps neutralisant, le complexe majeur d'histocompatibilité, l'immunité humorale, la cellule dendritique, l'immunité à médiation cellulaire, immunothérapie, récepteur de reconnaissance des pathogènes, complexe majeur d'histocompatibilité, Immunol, Vaccin, tolérance immunitaire, cellule dendritique, immunité humorale, immunité à médiation cellulaire, formulation du vaccin, vaccin vivant atténué, vaccin à sous-unités, immunité des muqueuses, mémoire immunologique, point de contrôle immunitaire, adjuvant du vaccin, immunopathologie et modulation immunitaire.

pH-responsive amphiphilic peptide nanofibers facilitate endosomal escape for cytosolic protein delivery

Published on 2026-06-16 by Tomonori Waku, Chikae Sakata, Tomoki Matsuda, Kotone Minato, Hiroyasu Takemoto, Kazuya Matsuo, Akio Kobori @NATURE

Abstract: Polymer Journal, Published online: 16 June 2026; doi:10.1038/s41428-026-01212-2We developed pH-responsive amphiphilic peptide nanofibers (NFs) that may facilitate cytosolic protein delivery by selectively destabilizing endosomal membranes. The NFs were based on β-sheet-forming peptides conjugated with oligoglutamic acid segments, and the number of Glu residues was varied to optimize pH-responsive activity. Optimized NFs showed strong membrane-destabilizing activity at mildly acidic pH but remai[...]


Our summary: The study presents pH-responsive amphiphilic peptide nanofibers designed to enhance cytosolic protein delivery. These nanofibers destabilize endosomal membranes at mildly acidic pH while remaining stable at neutral pH. When tested with ovalbumin in dendritic cells, they improved MHC class I presentation of the OVA-derived epitope.

pH-responsive, amphiphilic, peptide nanofibers, cytosolic delivery

Publication

Surface-nanostructured cellulose gauze with terminally aminated low-molecular-weight cellulose for adsorbing bacteria

Published on 2026-06-15 by Yuuki Hata, Sayaka Okamoto, Yudai Mizuuchi, Hiroshi Tanaka, Takeshi Serizawa @NATURE

Abstract: Polymer Journal, Published online: 15 June 2026; doi:10.1038/s41428-026-01214-0We demonstrated the self-assembly of terminally aminated low-molecular-weight cellulose into nanostructures on gauze microfibers and the bacterial adhesion-promoting effects of the resulting nanostructured gauze across a wide range of protein concentrations. Terminally aminated low-molecular-weight cellulose formed either nanospike or nanofibrillar-network structures, depending on the solvent and coagulant used during[...]


Our summary: The study explores the self-assembly of terminally aminated low-molecular-weight cellulose into nanostructures on gauze microfibers. These nanostructures enhance bacterial adhesion through electrostatic interactions, even in protein-rich environments. Different solvent and coagulant conditions lead to varied nanostructure formations, influencing adhesion properties.

cellulose, nanostructures, bacterial adhesion, self-assembly

Publication

Methods of treating non-hodgkin lymphoma

Patent published on the 2026-06-11 in WO under Ref WO2026122941 by TENEOTWO INC [US] (Lesley Robin [us], Humphrey Kathryn [gb], Brennan Denise Marie [us], Zhu Xu [us], Oki Yasuhiro [us], Olabode Damilola Omolola [us], Sermer David Julian [us], Chen Robert [gb])

Abstract: Methods of treating non-Hodgkin lymphoma by administering a multispecific antibody to a patient in need are provided. Methods of making such antibodies, and compositions, including pharmaceutical compositions, comprising such antibodies, are also provided.[...]


Our summary: This content discusses methods for treating non-Hodgkin lymphoma using multispecific antibodies. It includes the development of these antibodies and their pharmaceutical compositions. The focus is on providing effective treatment options for patients.

non-Hodgkin lymphoma, multispecific antibody, treatment methods, pharmaceutical compositions

Patent

Engineered dendritic cells with membrane-bound cytokine and uses thereof

Patent published on the 2026-06-11 in WO under Ref WO2026122810 by WASHINGTON UNIV [US] (Deselm Carl [us], Namen Shelby [us], Pandey Gaurav [us])

Abstract: Provided herein are dendritic cells comprising a chimeric receptor (e.g, a chimeric antigen receptor (CAR)) and a membrane-bound chimeric interferon (IFN) molecule. Also provided herein are dendritic cells comprising a chimeric receptor (e.g, a chimeric antigen receptor (CAR)) and a membrane-bound chimeric interleukin-2 (IL-2) family cytokine molecule. Also provided are methods of making such engineered dendritic cells and methods of using such engineered dendritic cells for various treatments.[...]


Our summary: Engineered dendritic cells are created with chimeric receptors and membrane-bound cytokines. These cells can express chimeric antigen receptors alongside chimeric interferon or interleukin-2 molecules. Methods for their production and therapeutic applications are also described.

dendritic cells, chimeric receptors, cytokines, immunotherapy

Patent

Systems and methods for lossless ion mobility spectromenter with axial diffusion constriction

Patent published on the 2026-06-11 in US under Ref US20260162952 by PURDUE RES FOUNDATION [US] (Larriba-andaluz Carlos [us])

Abstract: The invention generally relates to system and method for lossless ion mobility spectrometer with axial diffusion constriction. In certain aspects, the invention provides an ion mobility spectrometry system, the system comprising: an ion mobility drift cell comprising electrodes; and a central processing unit (CPU), and storage coupled to the CPU for storing instructions that when executed by the CPU cause the electrodes of the drift cell to apply varying electric fields within the drift cell to [...]


Our summary: The invention describes a lossless ion mobility spectrometer utilizing axial diffusion constriction. It includes a drift cell with electrodes and a CPU for controlling electric fields. This setup restricts axial diffusion of ions during separation.

ion mobility spectrometry, lossless detection, axial diffusion, drift cell

Patent

Bcg immunotherapy in diabetes and cns disorders

Patent published on the 2026-06-11 in WO under Ref WO2026123025 by THE GENERAL HOSPITAL CORP [US] (Faustman Denise [us])

Abstract: The invention relates to a method for regulating blood sugar levels in a subject in need thereof, the method comprising administering a therapeutically effective amount of a Bacillus Calmette Guerin (BCG) strain to the subject, thereby regulating the blood sugar levels in a subject.[...]


Our summary: The invention describes a method for regulating blood sugar levels using Bacillus Calmette Guerin (BCG) strain. This method is intended for subjects with diabetes and CNS disorders. Administration of BCG is aimed at achieving therapeutic effects on blood sugar levels.

BCG immunotherapy, diabetes, blood sugar regulation, CNS disorders

Patent

Jointly optimizing coordinated multipoint transmission and energy saving operations for inter/intra-du scenarios in o-ran networks

Patent published on the 2026-06-11 in WO under Ref WO2026122740 by MAVENIR SYSTEMS INC [US] (Taneja Mukesh [in])

Abstract: To address cell interference, a Coordinated Multipoint Transmission module is configured to decide Physical Resource Blocks to be blanked for each region of a cell along with a time interval for each cell. An Artificial Intelligence and Machine Learning assisted Low Energy Scheduling Solution module is configured to finds time intervals where a Distributed Unit for the cell does not communicate any data with the User Equipment in that cell and such time intervals can be used by a Radio Unit to s[...]


Our summary: The content discusses optimizing coordinated multipoint transmission and energy saving in O-RAN networks. It highlights a module that manages physical resource blocks to mitigate cell interference. Additionally, an AI/ML solution identifies idle communication intervals for energy savings.

Coordinated Multipoint, Energy Saving, O-RAN Networks, AI/ML Optimization

Patent

Self-timing circuit for semiconductor memory devices and memory device

Patent published on the 2026-06-11 in US under Ref US20260162719 by WEEBIT NANO LTD [IL] (Vershkov Maxim [il])

Abstract: [0000] A memory circuit (MEM) comprising an array (ARR) of bit cells (BC) arranged in rows of bit cells connected to a respective word line (WL) and in columns of bit cells connected to a respective one of bit lines (BL); a sense amplifier (S-Amp) circuit to be connected to the bit lines, an external clock input (In1) fed with an external clock signal (Ext-Clck) comprising external clock pulses having a first length of time, and a timing circuit (T-Cntl) to track a time taken to charge one of th[...]


Our summary: A memory circuit includes an array of bit cells connected to word and bit lines. It features a sense amplifier connected to the bit lines and a timing circuit that generates an internal clock signal. The internal clock pulses are defined by the longest duration between external clock pulses and the time taken to charge a bit line.

self-timing circuit, semiconductor memory, sense amplifier, internal clock signal

Patent

Sujets abordés : Immunologie, vaccinologie, formulation des vaccins, adjuvants, systèmes d'administration, modulation immunitaire, immunopathologie, mémoire immunitaire, reconnaissance des antigènes, interactions hôte-pathogène, efficacité des vaccins, maladies infectieuses, vaccins thérapeutiques, vaccins prophylactiques, immunologie cellulaire, immunologie moléculaire, ISO 14155, ISO 13485, ISO 9001, ISO 17025 et ISO 14971...

Contexte historique

1965
1970
1980
1980
1990
1960
1969
1976-05-28
1980
1990

(si la date est inconnue ou non pertinente, par exemple « mécanique des fluides », une estimation arrondie de son émergence notable est fournie)

Les images en pleine résolution et les téléchargements sont uniquement disponibles, et 100% gratuits, pour les membres inscrits.